ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Roland Hetzer
Vladimir Alexi-Meskishvili
Frank Merkle
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hetzer, R.
Right arrow Articles by Hennig, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hetzer, R.
Right arrow Articles by Hennig, E.
Related Collections
Right arrow Mechanical Circulatory Assistance

Ann Thorac Surg 2006;82:917-925
© 2006 The Society of Thoracic Surgeons

Original article: Cardiovascular

Improvement in Survival After Mechanical Circulatory Support With Pneumatic Pulsatile Ventricular Assist Devices in Pediatric Patients

Roland Hetzer, MD, PhD*, Evgenij V. Potapov, MD, Brigitte Stiller, MD, PhD, Yuguo Weng, MD, PhD, Michael Hübler, MD, Julia Lemmer, MD, Vladimir Alexi-Meskishvili, MD, PhD, Matthias Redlin, MD, Frank Merkle, ECCP, Friedrich Kaufmann, Dipl Eng, Ewald Hennig, PhD

Deutsches Herzzentrum Berlin, Berlin, Germany

Accepted for publication March 10, 2006.

* Address correspondence to Dr Hetzer, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, Berlin 13353, Germany (Email: hetzer{at}dhzb.de).

Presented at the Forty-first Annual Meeting of The Society of Thoracic Surgeons, Tampa, FL, Jan 24–26, 2005.

BACKGROUND: Pediatric size pneumatically driven extracorporeal ventricular assist devices (VAD) for infants and small children were introduced into clinical routine in 1992. In the initial period, the results in infants were poor. Since then, several improvements have been introduced with regard to the cannulas, connectors, heparin coating of the blood pump inner surface, anticoagulant treatment and coagulation monitoring, and earlier decision-making in favor of pump implantation before irreversible shock has set in.

METHODS: Since 1990 and as of January 1, 2005, 62 Berlin Heart Excor systems have been implanted in patients below 18 years of age at our institution. The patients were divided into two groups according to the period of treatment: period 1, devices implanted between 1990 and 1998 (n = 34), and period 2, devices implanted between 1999 and 2004 (n = 28). We compared our experience during the earlier and later periods.

RESULTS: There were no significant differences in the preoperative patient data between the two periods except for time of support (17.9 ± 27.7 days versus 53.2 ± 83.9 days, p = 0.001). In period 1, more patients needed a biventricular VAD whereas in period 2, more patients were effectively treated with a left VAD (p = 0.05). In the later period, the chest could be primarily closed in a significantly higher percentage of infants (0% versus 89%, p = 0.012), and more infants could be extubated on the VAD (0% versus 55%, p = 0.16). Discharge from the hospital after either weaning from the system or heart transplantation was achieved for 35% in period 1 and for 68% in period 2 (p = 0.029). Whereas in period 1 there were no survivors in the group of children younger than 1 year old, during period 2, survival in this age group was similar to that of the two groups of older children (p = 0.024). There was a significant improvement in the discharge rate in period 2 in patients with cardiomyopathy (43% versus 76%, p = 0.045) and postcardiotomy heart failure (0% versus 57%, p = 0.01).

CONCLUSIONS: Earlier implantation of VADs, heparin coating of the blood pumps, and substantial modifications in cannula design, anticoagulation, and the coagulation monitoring regimen have led to a significant increase in the survival and discharge rate, especially among children under 1 year of age. The pediatric size Berlin Heart Excor VAD is a valuable option as a bridge to heart transplantation or recovery for children suffering from cardiogenic shock.




This article has been cited by other articles:


Home page
 ICVTSHome page
K. Januszewska, E. Malec, J. Birnbaum, M. Loeff, R. Sodian, C. Schmitz, H. Netz, and B. Reichart
Ventricular assist device as a bridge to heart transplantation in children
Interactive CardioVascular and Thoracic Surgery, November 1, 2009; 9(5): 807 - 810.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Imamura, A. M. Dossey, P. Prodhan, M. Schmitz, E. Frazier, U. Dyamenahalli, A. Bhutta, W. R. Morrow, and R. D.B. Jaquiss
Bridge to Cardiac Transplant in Children: Berlin Heart versus Extracorporeal Membrane Oxygenation.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1894 - 1901.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Nicolini and T. Gherli
Alternatives to transplantation in the surgical therapy for heart failure
Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 214 - 228.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.